Mathé G
Biomed Pharmacother. 1995;49(4):161-7. doi: 10.1016/0753-3322(96)82616-3.
The author has tried to extrapolate on several neurological diseases of the ageing, Knoll's proposition to treat Parkinson's disease chronically for relapse prevention, by MAO-B. At this occasion, the author makes a critical review of the clinical trial results concerning the new different series of depression treatments, as most authors propose today to use some new ones not only in depression, but in Parkinson's and Alzheimer's diseases and in ageing.
作者试图推断衰老过程中的几种神经疾病，即诺尔提出的通过单胺氧化酶B（MAO-B）长期治疗帕金森病以预防复发的观点。在此之际，作者对有关新型不同系列抑郁症治疗方法的临床试验结果进行了批判性回顾，因为如今大多数作者提议不仅在抑郁症中，而且在帕金森病、阿尔茨海默病以及衰老相关病症中使用一些新的治疗方法。
